Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This reflects an internal update/version control rather than a change to visible content.
    Difference
    0.0%
    Check dated 2026-08-31T18:15:26.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page shows updated Study Record Dates with new entries like 2026-08-19 and removal of older dates. These changes reflect maintenance of the record rather than modifications to the trial content or results.
    Difference
    0.1%
    Check dated 2026-08-24T21:32:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Plain Language Summary section removed from the study page, removing the lay-friendly overview of the trial for general readers. This reduces quick, accessible understanding of the study’s purpose and design for non-experts.
    Difference
    0.0%
    Check dated 2026-08-17T17:59:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor version update to the page's documentation/template.
    Difference
    0.0%
    Check dated 2026-08-10T15:30:41.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a minor version update to the underlying page.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:37.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This appears to be an update to the document version without changes to the study content or its features.
    Difference
    0.0%
    Check dated 2026-07-05T14:47:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.